Q-omics provides the consensus-scored LINC01588 profile across patient tissues and cancer cell-line models. LINC01588 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC01588 is differentially expressed in 12, with the highest sampling consensus in COAD. Additionally, LINC01588 RNA expression shows 18,248 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and COAD as cancer lineages where LINC01588 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01588 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01588 survival associations across molecular data types. LINC01588 RNA expression shows survival associations in the most cancer types (23), followed by mutation status (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01588 RNA expression–survival associations across cancer types. High LINC01588 expression shows unfavorable associations in UVM, KIRC, BLCA, LGG, KIRP and COAD. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for LINC01588 RNA expression.
This table summarizes LINC01588 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01588. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01588 shows lower tumor expression in COAD and KICH and higher tumor expression in LUAD, BLCA, STAD and BRCA. The COAD box plot shows higher LINC01588 RNA expression in normal versus tumor tissue (log2 FC = −0.695, t-test p < 0.001).
This table shows molecular features associated with LINC01588 in patient tissues and cancer cell lines. In patient samples, LINC01588 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
